Growth & profitability
- Revenue has declined 4.2% per year over the past 5 years.
Financial health
- Total debt ($5.7B) exceeds cash ($2.6B); net debt is $3.1B.
- Total debt has grown faster than revenue (12.9% vs -4.2% per year).
7 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2026 | $15.1B | $185M | 21.8% | 0.0% | $340M | $5.7B | $2.6B |
| 2025 | $15.1B | $252M | 20.9% | 0.0% | $337M | $3.0B | $1.8B |
| 2024 | $16.1B | -$340M | 17.8% | 0.0% | -$197M | $3.0B | $1.6B |
| 2023 | $17.0B | -$1.4B | 14.8% | 0.0% | -$84M | $3.1B | $1.8B |
| 2021 | $18.7B | -$2.3B | 11.3% | 0.0% | -$871M | $3.1B | $2.2B |
| 2020 | $19.4B | -$2.0B | 11.4% | 0.0% | -$408M | $209M | $24M |
| 2019 | $20.3B | -$939M | 12.8% | 0.0% | — | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Dec '25 | $3.9B | $57M | 21.8% | 0.0% | $208M | $3.7B | $1.3B |
| Sep '25 | $3.7B | $68M | 21.5% | 0.0% | — | $3.0B | $1.3B |
| Jun '25 | $3.7B | $56M | 21.3% | 0.0% | -$267M | $3.0B | $1.5B |
| Mar '25 | $3.8B | $69M | 21.7% | 0.0% | $341M | $3.0B | $1.8B |
| Dec '24 | $3.7B | $215M | 20.4% | 0.0% | $151M | $3.0B | $1.5B |
| Sep '24 | $3.8B | -$43M | 19.9% | 0.0% | $15M | $3.0B | $1.3B |
| Jun '24 | $3.7B | $11M | 21.5% | 0.0% | -$170M | $3.0B | $1.3B |
| Mar '24 | $3.9B | -$45M | 18.6% | 0.0% | -$57M | $3.0B | $1.6B |
| Dec '23 | $3.9B | -$12M | 19.1% | 0.0% | $262M | $3.6B | $1.7B |
| Sep '23 | $4.1B | -$142M | 16.0% | 0.0% | -$129M | $3.1B | $1.4B |
| Jun '23 | $4.2B | -$141M | 17.7% | 0.0% | -$273M | $3.1B | $1.5B |
| Mar '23 | $4.3B | -$737M | 15.1% | 0.0% | -$142M | $3.1B | $1.8B |
| Dec '22 | $4.3B | -$106M | 16.4% | 0.0% | $33M | $3.0B | $2.0B |
| Sep '22 | $4.2B | -$281M | 13.5% | 0.0% | $134M | $3.0B | $1.9B |
| Jun '22 | $4.3B | -$250M | 14.2% | 0.0% | -$109M | $3.0B | $1.9B |
| Mar '22 | $4.4B | -$229M | 13.7% | 0.0% | $9M | $3.1B | $2.1B |
| Dec '21 | $4.6B | -$731M | 12.2% | 0.0% | — | $3.1B | $2.2B |
| Sep '21 | $4.6B | -$690M | 11.1% | 0.0% | -$429M | $392M | $735M |
| Jun '21 | $4.8B | -$389M | 12.4% | 0.0% | -$388M | — | — |
| Mar '21 | $4.8B | -$494M | 9.5% | 0.0% | -$508M | — | — |
How the market has priced KD against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Kyndryl Holdings, Inc.'s revenue has declined 4.2% per year. These are computed facts, not advice.
As of FY2026, Kyndryl Holdings, Inc. reported $5.7B of total debt against $2.6B of cash.
In FY2026, gross margin was 21.8%, operating margin —, and net margin 1.2%.
As of Jun '26, Kyndryl Holdings, Inc. traded at a price-to-earnings ratio of about 12.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.